ARNICA/PLUMBUM/Mellitum ampoules

Pack size:10 x 1 ml Dosage form:Ampoules

Arnica/Plumbum mellitum, liquid dilution for injection. Indications: In accordance with anthroposophical understanding of man and nature. These include: reintegration of the ego and sensory organization into the vascular system in cases of increased deposit and hardening tendencies, e.g. general vascular sclerosis, cerebral circulatory disorders.

For risks and side effects, read the package insert and ask your doctor or pharmacist.


INSTRUCTIONS FOR USE: INFORMATION FOR THE USER

Arnica/Plumbum mellitum, liquid dilution for injection

Composition:
1 ampoule contains: Arnica montana e planta tota ferm 33c Dil. D29 0.1 g (HAB, Vs. 33c), Plumbum mellitum Dil. D29 aquos. 0.2 g (HAB, Vs. 6). Other ingredients: Sodium chloride, sodium bicarbonate, water for injections.

Indications:
According to anthroposophical understanding of man and nature. These include: reintegration of the ego and sensory organization into the vascular system in cases of increased deposit and hardening tendencies, e.g., general vascular sclerosis, cerebral circulatory disorders.

Contraindications:
None known.

Precautions for use and warnings:
This medicine should not be used on children under 18 years of age.

Dosage and method of administration:
Unless otherwise prescribed, adults should inject 1 ml subcutaneously 2 to 3 times weekly.

Duration of use:
Unless otherwise prescribed by a doctor, Arnica/Plumbum mellitus should not be administered for longer than 8 weeks without interruption.

Side effects:
None known.

Contents:
10 x 1 ml

Pharmaceutical entrepreneur and manufacturer:
WALA Heilmittel GmbH
Dorfstraße 1
73087 Bad Boll/Eckwälden

This package leaflet was last revised in January 2025.

Source: Information from the Wala catalogue
as of: 03/2025

Areas of application: According to anthroposophical understanding of man and nature. These include: reintegration of the ego and sensory organization into the vascular system in cases of increased deposit and hardening tendencies, e.g., general vascular sclerosis, cerebral circulatory disorders.